|
Neurontin
Neurontin (gabapentin) was approved by the Food and Drug Administration (FDA) in 1994 for the control
of partial seizures due to epilepsy in adults and children. It is also approved for management of
postherpetic neuralgia (PHN) caused by shingles (herpes zoster). Neurontin affects chemicals and nerves
in the body that are involved in the cause of seizures and certain types of pain. The exact way it
works is unknown.
Neurontin was originally sold by Parke-Davis, a subsidiary of Warner-Lambert, which in turn was acquired
by Pfizer, Inc., in 2000. It has been uncovered that the makers of Neurontin, have paid thousands of
dollars to doctors for prescribing the drug for illnesses unrelated to its original, FDA-approved purpose
including bipolar disorder, ADD, migraines, neuralgia, neuropathy, restless leg syndrome, and drug and
alcohol withdrawal seizures In spite of concerns for patient health and medical ethics, the drug makers
devised a reckless, profit-making scheme designed to access the drug to a wider market.
Neurontin has been associated with suicides, suicidal thoughts, suicidal ideation, hostility, paranoia
and anxiety.
If you or a loved one is in need of legal assistance, call Gonzalez & Garcia Toll Free at (800) 352-HURT or submit
an online questionnaire. The initial consultation is free of charge, and
if we agree to handle your case, we will work on a contingency fee basis, which
means we get paid for our services only if there is a monetary recovery of funds.
In many cases, a lawsuit must be filed before an applicable expiration date,
known as a statute of limitations. Please call right away to ensure that you
do not waive your right to possible compensation.
© Copyright 2008 – Gonzalez & Garcia, MegaHunter Inc. and Attorney Hunter, an
Attorney Directory-Lawyers, Law Firms, Attorneys. Lawyer Websites – Attorney Websites – Law
Firm Websites – Legal Websites designed by
MegaHunter, Inc. All Rights Reserved. | 
